221 related articles for article (PubMed ID: 32142606)
1. Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM.
Nagy G; Attah IK; Conant CR; Liu W; Garimella SVB; Gunawardena HP; Shaw JB; Smith RD; Ibrahim YM
Anal Chem; 2020 Apr; 92(7):5004-5012. PubMed ID: 32142606
[TBL] [Abstract][Full Text] [Related]
2. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
[TBL] [Abstract][Full Text] [Related]
3. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
[TBL] [Abstract][Full Text] [Related]
4. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
5. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
[TBL] [Abstract][Full Text] [Related]
6. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Intact Antibody Drug Conjugate Variants Using Microfluidic Capillary Electrophoresis-Mass Spectrometry.
Redman EA; Mellors JS; Starkey JA; Ramsey JM
Anal Chem; 2016 Feb; 88(4):2220-6. PubMed ID: 26765745
[TBL] [Abstract][Full Text] [Related]
8. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
[TBL] [Abstract][Full Text] [Related]
9. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
[TBL] [Abstract][Full Text] [Related]
10. [Bioanalysis in the development of antibody-drug conjugates].
Li XL; Chen XY; Zhong DF
Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519
[TBL] [Abstract][Full Text] [Related]
11. Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate.
Rago B; Clark T; King L; Zhang J; Tumey LN; Li F; Barletta F; Wei C; Leal M; Hansel S; Han X
Bioanalysis; 2016 Nov; 8(21):2205-2217. PubMed ID: 27682846
[TBL] [Abstract][Full Text] [Related]
12. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
Gilroy JJ; Eakin CM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Time-Warping Correction for Shifts in Ultrahigh Resolving Power Ion Mobility Spectrometry and Structures for Lossless Ion Manipulations.
Hollerbach AL; Conant CR; Nagy G; Monroe ME; Gupta K; Donor M; Giberson CM; Garimella SVB; Smith RD; Ibrahim YM
J Am Soc Mass Spectrom; 2021 Apr; 32(4):996-1007. PubMed ID: 33666432
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ADCs by Native Mass Spectrometry.
Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
[TBL] [Abstract][Full Text] [Related]
15. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates.
Nadkarni DV; Lee J; Jiang Q; Patel V; Sriskanda V; Dutta K; Meyer DM
Mol Pharm; 2021 Mar; 18(3):889-897. PubMed ID: 33470823
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
Huang RY; Chen G
Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
[TBL] [Abstract][Full Text] [Related]
17. SLIM Ultrahigh Resolution Ion Mobility Spectrometry Separations of Isotopologues and Isotopomers Reveal Mobility Shifts due to Mass Distribution Changes.
Wojcik R; Nagy G; Attah IK; Webb IK; Garimella SVB; Weitz KK; Hollerbach A; Monroe ME; Ligare MR; Nielson FF; Norheim RV; Renslow RS; Metz TO; Ibrahim YM; Smith RD
Anal Chem; 2019 Sep; 91(18):11952-11962. PubMed ID: 31450886
[TBL] [Abstract][Full Text] [Related]
18. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
[TBL] [Abstract][Full Text] [Related]
19. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
[TBL] [Abstract][Full Text] [Related]
20. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
Friese OV; Smith JN; Brown PW; Rouse JC
MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
